Outlook Therapeutics Inc. (OTLK) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Outlook Therapeutics Inc.

    NASDAQ: OTLK · Real-Time Price · USD
    1.09
    0.03 (2.83%)
    At close: Oct 06, 2025, 11:02 AM

    Outlook Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    PE Ratio
    		 -1.31 -0.94 -3.92 -6.23
    PEG Ratio
    		 0.09 0.04 0.37 0.13
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 -1.36 -3.83 29.62 71.91
    P/FCF Ratio
    		 -1.44 -1.29 -4.57 -6.11
    P/OCF Ratio
    		 -1.44 -1.29 -4.57 -6.11
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 -0.41 -2.46 1.25 2.58
    Quick Ratio
    		 0.64 0.66 1.39 3.19
    Current Ratio
    		 0.64 0.66 1.39 3.19
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -22.71 -34.06 -42.41 -55.26
    Return on Equity
    		 1.03 4.09 -7.56 -11.54
    Return on Assets
    		 -2.61 -1.83 -2.32 -2.33
    Return on Invested Capital
    		 -4.55 -2.52 -3.19 -3.04
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist